285 related articles for article (PubMed ID: 18562811)
1. Statin-drug interactions: not a class effect.
Frishman WH; Horn J
Cardiol Rev; 2008; 16(4):205-12. PubMed ID: 18562811
[TBL] [Abstract][Full Text] [Related]
2. Drug-drug interactions that interfere with statin metabolism.
Hirota T; Ieiri I
Expert Opin Drug Metab Toxicol; 2015; 11(9):1435-47. PubMed ID: 26058399
[TBL] [Abstract][Full Text] [Related]
3. Statin-induced myotoxicity: pharmacokinetic differences among statins and the risk of rhabdomyolysis, with particular reference to pitavastatin.
Catapano AL
Curr Vasc Pharmacol; 2012 Mar; 10(2):257-67. PubMed ID: 22022768
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment.
Chatzizisis YS; Koskinas KC; Misirli G; Vaklavas C; Hatzitolios A; Giannoglou GD
Drug Saf; 2010 Mar; 33(3):171-87. PubMed ID: 20158283
[TBL] [Abstract][Full Text] [Related]
5. Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia.
Kostapanos MS; Milionis HJ; Elisaf MS
Am J Cardiovasc Drugs; 2010; 10(1):11-28. PubMed ID: 20104931
[TBL] [Abstract][Full Text] [Related]
6. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.
Williams D; Feely J
Clin Pharmacokinet; 2002; 41(5):343-70. PubMed ID: 12036392
[TBL] [Abstract][Full Text] [Related]
8. Safety considerations for statins.
Bolego C; Baetta R; Bellosta S; Corsini A; Paoletti R
Curr Opin Lipidol; 2002 Dec; 13(6):637-44. PubMed ID: 12441888
[TBL] [Abstract][Full Text] [Related]
9. Suggested clinical approach for the diagnosis and management of 'statin intolerance' with an emphasis on muscle-related side-effects.
Sivashanmugarajah A; Fulcher J; Sullivan D; Elam M; Jenkins A; Keech A
Intern Med J; 2019 Sep; 49(9):1081-1091. PubMed ID: 31507054
[TBL] [Abstract][Full Text] [Related]
10. [Interaction of statins with clopidogrel].
Von Scheidt W
Internist (Berl); 2004 Mar; 45(3):363-5. PubMed ID: 14997315
[No Abstract] [Full Text] [Related]
11. Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma.
Calderon RM; Cubeddu LX; Goldberg RB; Schiff ER
Mayo Clin Proc; 2010 Apr; 85(4):349-56. PubMed ID: 20360293
[TBL] [Abstract][Full Text] [Related]
12. Current overview of statin-induced myopathy.
Rosenson RS
Am J Med; 2004 Mar; 116(6):408-16. PubMed ID: 15006590
[TBL] [Abstract][Full Text] [Related]
13. Frequency and clinical relevance of drug interactions with lovastatin and simvastatin: an observational database study.
Tirkkonen T; Ryynänen A; Vahlberg T; Irjala K; Klaukka T; Huupponen R; Laine K
Drug Saf; 2008; 31(3):231-40. PubMed ID: 18302447
[TBL] [Abstract][Full Text] [Related]
14. [Statin intolerance].
Graversen CB; Larsen ML; Schmidt EB
Ugeskr Laeger; 2015 Aug; 177(36):. PubMed ID: 26324293
[TBL] [Abstract][Full Text] [Related]
15. [Adverse effects of statins].
Andréjak M; Gras V; Massy ZA; Caron J
Therapie; 2003; 58(1):77-83. PubMed ID: 12822204
[TBL] [Abstract][Full Text] [Related]
16. Safety of statins: focus on clinical pharmacokinetics and drug interactions.
Bellosta S; Paoletti R; Corsini A
Circulation; 2004 Jun; 109(23 Suppl 1):III50-7. PubMed ID: 15198967
[TBL] [Abstract][Full Text] [Related]
17. Statins and myotoxicity: a therapeutic limitation.
Tiwari A; Bansal V; Chugh A; Mookhtiar K
Expert Opin Drug Saf; 2006 Sep; 5(5):651-66. PubMed ID: 16907655
[TBL] [Abstract][Full Text] [Related]
18. A safety look at currently available statins.
Moghadasian MH
Expert Opin Drug Saf; 2002 Sep; 1(3):269-74. PubMed ID: 12904142
[TBL] [Abstract][Full Text] [Related]
19. [Antilipemic therapy and rhabdomyolysis].
Paragh G; Balogh Z; Romics L
Orv Hetil; 2003 Mar; 144(11):515-20. PubMed ID: 12731338
[TBL] [Abstract][Full Text] [Related]
20. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association.
Newman CB; Preiss D; Tobert JA; Jacobson TA; Page RL; Goldstein LB; Chin C; Tannock LR; Miller M; Raghuveer G; Duell PB; Brinton EA; Pollak A; Braun LT; Welty FK;
Arterioscler Thromb Vasc Biol; 2019 Feb; 39(2):e38-e81. PubMed ID: 30580575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
